Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Mind Medicine Inc (NASDAQ: MNMD) closed at $9.65 up 3.43% from its previous closing price of $9.33. In other words, the price has increased by $3.43 from its previous closing price. On the day, 0.9 million shares were traded. MNMD stock price reached its highest trading level at $9.7 during the session, while it also had its lowest trading level at $9.26.
Ratios:
For a deeper understanding of Mind Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23. On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.Chardan Capital Markets initiated its Buy rating on December 20, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 25 ’25 when Sullivan Mark sold 11,491 shares for $6.80 per share. The transaction valued at 78,139 led to the insider holds 305,130 shares of the business.
Karlin Daniel sold 7,848 shares of MNMD for $53,366 on Jun 25 ’25. The Chief Medical Officer now owns 438,329 shares after completing the transaction at $6.80 per share. On Jun 25 ’25, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 26,491 shares for $6.80 each. As a result, the insider received 180,139 and left with 830,065 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 734248256 and an Enterprise Value of 592446656.
Stock Price History:
The Beta on a monthly basis for MNMD is 3.27, which has changed by 0.49612403 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $11.02, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 4.93%, while the 200-Day Moving Average is calculated to be 28.40%.
Shares Statistics:
For the past three months, MNMD has traded an average of 1.23M shares per day and 1115850 over the past ten days. A total of 75.80M shares are outstanding, with a floating share count of 72.52M. Insiders hold about 4.01% of the company’s shares, while institutions hold 54.47% stake in the company. Shares short for MNMD as of 1756425600 were 10192548 with a Short Ratio of 8.32, compared to 1753920000 on 10472811. Therefore, it implies a Short% of Shares Outstanding of 10192548 and a Short% of Float of 13.5.
Earnings Estimates
The current assessment of Mind Medicine Inc (MNMD) involves the perspectives of 7.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.43 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$1.61 and -$1.95 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.85, with 8.0 analysts recommending between -$1.0 and -$2.47.
